Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↓ 100% vs avg
Percentile
P0
Near historical low
Average
11.79%
Historical baseline
PeriodValueYoY Change
20250.00%-
20240.00%-100.0%
202347.15%-
20220.00%-